awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q28285888-051A7EBF-DE9A-4BBA-A7EB-617032C11136
Q28285888-051A7EBF-DE9A-4BBA-A7EB-617032C11136
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28285888-051A7EBF-DE9A-4BBA-A7EB-617032C11136
Thematic review series: lipid posttranslational modifications. Fighting parasitic disease by blocking protein farnesylation
P2860
Q28285888-051A7EBF-DE9A-4BBA-A7EB-617032C11136
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28285888-051A7EBF-DE9A-4BBA-A7EB-617032C11136
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3ac1466b49ea879ef84900cf280f40651a5b69f8
P2860
Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.